DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Hans Herfarth, MD, PhD, has affiliations with Alivio, Allergan, AMAG, Boehringer-Ingelheim, Celtrion, Finch, Lycera, Merck, Pfizer, PureTech, Seres (Consultant); Artizan, Pfizer (Research).
Miguel Reguerio, MD, has affiliations with AbbVie, Allergan, Amgen, Celgene, Genentech, Gilead, Janssen, Miraca Labs, Pfizer, Salix, Seres, Takeda, UCB (Advisory Board, Consultant); AbbVie, Janssen, Takeda (Research); AbbVie, Janssen, Pfizer, Salix, Shire, Takeda, UCB (Unrestricted Educational Grants).
Planners and Managers
The PIM planners and managers have nothing to disclose. RMEI Medical Education, LLC planners and managers have nothing to disclose. The Crohn’s & Colitis Foundation planners and managers have nothing to disclose.